Individual differences in prefrontal cortex function and the transition from drug use to drug dependence

Neuroscience and Biobehavioral Reviews

Volumn 35, Issue 2, 2010, Pages 232-247

  George, Olivier ^a   Koob, George F ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

Cognitive; Emotion; Habits; Incentive salience; Individual differences; Loss of control; Module; Pain; Prefrontal; Reward; Stress

Indexed keywords

AMYGDALOID NUCLEUS; ASSOCIATION; BRAIN FUNCTION; COGNITION; CORPUS STRIATUM; DECISION MAKING; DISEASE MODEL; DRUG DEPENDENCE; DRUG SELF ADMINISTRATION; EMOTION; HABIT; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MESOLIMBIC DOPAMINERGIC SYSTEM; NONHUMAN; PAIN; PATHOLOGICAL ANATOMY; PREFRONTAL CORTEX; PRIORITY JOURNAL; REVIEW; REWARD; SENSITIVITY ANALYSIS; STRESS; WITHDRAWAL SYNDROME;

AMYGDALA; ANIMALS; BEHAVIOR, ADDICTIVE; COGNITION; DISEASE PROGRESSION; DOPAMINE; EXECUTIVE FUNCTION; HUMANS; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; INDIVIDUALITY; OPIOID PEPTIDES; PITUITARY-ADRENAL SYSTEM; PREFRONTAL CORTEX; SOCIAL CONTROL, INFORMAL; SUBSTANCE-RELATED DISORDERS;

EID: 78650274939     PISSN: 01497634     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neubiorev.2010.05.002     Document Type: Review

References (251)

1. Ahmed S.H., Koob G.F. Transition from moderate to excessive drug intake: change in hedonic set point. Science 1998, 282:298-300.
2. Alheid G.F., Heimer L. New perspectives in basal forebrain organization of special relevance for neuropsychiatric disorders: the striatopallidal, amygdaloid, and corticopetal components of substantia innominata. Neuroscience 1988, 27:1-39.
3. Amat J., Baratta M.V., Paul E., Bland S.T., Watkins L.R., Maier S.F. Medial prefrontal cortex determines how stressor controllability affects behavior and dorsal raphe nucleus. Nat. Neurosci. 2005, 8:365-371.
4. Anthony J.C., Warner L.A., Kessler R.C. Comparative epidemiology of dependence on tobacco, alcohol, controlled substances, and inhalants. Basic findings from the National Comorbidity Survey. Exp. Clin. Psychopharmacol. 1994, 2:244-268.
5. Antoniou K., Papathanasiou G., Papalexi E., Hyphantis T., Nomikos G.G., Spyraki C., Papadopoulou-Daifoti Z. Individual responses to novelty are associated with differences in behavioral and neurochemical profiles. Behav. Brain Res. 2008, 187:462-472.
6. Aytaclar S., Tarter R.E., Kirisci L., Lu S. Association between hyperactivity and executive cognitive functioning in childhood and substance use in early adolescence. J. Am. Acad. Child Adolesc. Psychiatry 1999, 38:172-178.
7. Baddeley A. The fractionation of working memory. Proc. Natl. Acad. Sci. U.S.A. 1996, 93(24):13468-13472.
8. Balleine B.W., Dickinson A. Goal-directed instrumental action: contingency and incentive learning and their cortical substrates. Neuropharmacology 1998, 37:407-419.
9. Bannerman D.M., Rawlins J.N., McHugh S.B., Deacon R.M., Yee B.K., Bast T., Zhang W.N., Pothuizen H.H., Feldon J. Regional dissociations within the hippocampus-memory and anxiety. Neurosci. Biobehav. Rev. 2004, 28:273-283.
10. Barrot M., Abrous D.N., Marinelli M., Rouge-Pont F., Le Moal M., Piazza P.V. Influence of glucocorticoids on dopaminergic transmission in the rat dorsolateral striatum. Eur. J. Neurosci. 2001, 13:812-818.
11. Barrot M., Marinelli M., Abrous D.N., Rouge-Pont F., Le Moal M., Piazza P.V. The dopaminergic hyper-responsiveness of the shell of the nucleus accumbens is hormone-dependent. Eur. J. Neurosci. 2000, 12:973-979.
12. Losing Control: How and Why People Fail at Self-Regulation 1994, Academic Press, San Diego. R.F. Baumeister, T.F. Heatherton, D.M. Tice (Eds.).
13. Baumeister R.D., Heatherton T.F., Tice D.M. Losing Control 2003, Academic Press, New York.
14. Beaver J.D., Lawrence A.D., Passamonti L., Calder A.J. Appetitive motivation predicts the neural response to facial signals of aggression. J. Neurosci. 2008, 28:2719-2725.
15. Bechara A. Decision making, impulse control and loss of willpower to resist drugs: a neurocognitive perspective. Nat. Neurosci. 2005, 8:1458-1463.
16. Bechara A., Tranel D., Damasio H. Characterization of the decision-making deficit of patients with ventromedial prefrontal cortex lesions. Brain 2000, 123(Pt 11):2189-2202.
17. Bechara A., Tranel D., Damasio H., Adolphs R., Rockland C., Damasio A.R. Double dissociation of conditioning and declarative knowledge relative to the amygdala and hippocampus in humans. Science 1995, 269:1115-1118.
18. Belin D., Everitt B.J. Cocaine seeking habits depend upon dopamine-dependent serial connectivity linking the ventral with the dorsal striatum. Neuron 2008, 57:432-441.
19. Belin D., Jonkman S., Dickinson A., Robbins T.W., Everitt B.J. Parallel and interactive learning processes within the basal ganglia: relevance for the understanding of addiction. Behav. Brain Res. 2009, 199:89-102.
20. Belin D., Mar A.C., Dalley J.W., Robbins T.W., Everitt B.J. High impulsivity predicts the switch to compulsive cocaine-taking. Science 2008, 320:1352-1355.
21. Ben-Shahar O., Keeley P., Cook M., Brake W., Joyce M., Nyffeler M., Heston R., Ettenberg A. Changes in levels of D1, D2, or NMDA receptors during withdrawal from brief or extended daily access to IV cocaine. Brain Res. 2007, 1131:220-228.
22. Ben-Shahar O., Obara I., Ary A.W., Ma N., Mangiardi M.A., Medina R.L., Szumlinski K.K. Extended daily access to cocaine results in distinct alterations in Homer 1b/c and NMDA receptor subunit expression within the medial prefrontal cortex. Synapse 2009, 63:598-609.
23. Berridge K.C., Robinson T.E., Aldridge J.W. Dissecting components of reward: 'liking', 'wanting', and learning. Curr. Opin. Pharmacol. 2009, 9:65-73.
24. Besson J.M. The neurobiology of pain. Lancet 1999, 353:1610-1615.
25. Birrell J.M., Brown V.J. Medial frontal cortex mediates perceptual attentional set shifting in the rat. J. Neurosci. 2000, 20:4320-4324.
26. Bishop S.J., Duncan J., Lawrence A.D. State anxiety modulation of the amygdala response to unattended threat-related stimuli. J. Neurosci. 2004, 24:10364-10368.
27. Block A.E., Dhanji H., Thompson-Tardif S.F., Floresco S.B. Thalamic-prefrontal cortical-ventral striatal circuitry mediates dissociable components of strategy set shifting. Cereb. Cortex 2007, 17:1625-1636.
28. Boakes R. Performance on learning to associate a stimulus with positive reinforcement 1977, 67-97. Operant-Pavlovian Interactions, Erlbaum, Hillsdale, NJ. H. Davis, H. Hurwitz (Eds.).
29. Bowers M.S., McFarland K., Lake R.W., Peterson Y.K., Lapish C.C., Gregory M.L., Lanier S.M., Kalivas P.W. Activator of G protein signaling 3: a gatekeeper of cocaine sensitization and drug seeking. Neuron 2004, 42:269-281.
30. Bradberry C.W., Gruen R.J., Berridge C.W., Roth R.H. Individual differences in behavioral measures: correlations with nucleus accumbens dopamine measured by microdialysis. Pharmacol. Biochem. Behav. 1991, 39:877-882.
31. Brands B., Blake J., Sproule B., Gourlay D., Busto U. Prescription opioid abuse in patients presenting for methadone maintenance treatment. Drug Alcohol Depend. 2004, 73:199-207.
32. Briand L.A., Flagel S.B., Garcia-Fuster M.J., Watson S.J., Akil H., Sarter M., Robinson T.E. Persistent alterations in cognitive function and prefrontal dopamine D2 receptors following extended, but not limited, access to self-administered cocaine. Neuropsychopharmacology 2008, 33:2969-2980.
33. Cain M.E., Denehy E.D., Bardo M.T. Individual differences in amphetamine self-administration: the role of the central nucleus of the amygdala. Neuropsychopharmacology 2008, 33:1149-1161.
34. Canli T. Functional brain mapping of extraversion and neuroticism: learning from individual differences in emotion processing. J. Pers. 2004, 72:1105-1132.
35. Canli T., Gabrieli J.D. Imaging gender differences in sexual arousal. Nat. Neurosci. 2004, 7:325-326.
36. Carboni, E., Vacca, C., 2003. Conditioned place preference: a simple method for investigating reinforcing properties in laboratory animals. In: Wang, J.Q. (Ed.), Drugs of Abuse: Neurological Reviews and Protocols. Methods in Molecular Medicine, vol. 79. Humana Press, Totowa, NJ, pp. 481-498.
37. Carr D.B., Sesack S.R. Projections from the rat prefrontal cortex to the ventral tegmental area: target specificity in the synaptic associations with mesoaccumbens and mesocortical neurons. J. Neurosci. 2000, 20:3864-3873.
38. Casey K.L. Concepts of pain mechanisms: the contribution of functional imaging of the human brain. Prog. Brain Res. 2000, 129:277-287.
39. Casey K.L., Minoshima S., Morrow T.J., Koeppe R.A. Comparison of human cerebral activation pattern during cutaneous warmth, heat pain, and deep cold pain. J. Neurophysiol. 1996, 76:571-581.
40. Cheng J., Feenstra M.G. Individual differences in dopamine efflux in nucleus accumbens shell and core during instrumental learning. Learn. Mem. 2006, 13:168-177.
41. Childress A.R., Mozley P.D., McElgin W., Fitzgerald J., Reivich M., O'Brien C.P. Limbic activation during cue-induced cocaine craving. Am. J. Psychiatry 1999, 156:11-18.
42. Coccaro E.F., McCloskey M.S., Fitzgerald D.A., Phan K.L. Amygdala and orbitofrontal reactivity to social threat in individuals with impulsive aggression. Biol. Psychiatry 2007, 62:168-178.
43. Coghill R.C., McHaffie J.G., Yen Y.F. Neural correlates of interindividual differences in the subjective experience of pain. Proc. Natl. Acad. Sci. U.S.A. 2003, 100:8538-8542.
44. Cohen N.J., Squire L.R. Preserved learning and retention of pattern-analyzing skill in amnesia: dissociation of knowing how and knowing that. Science 1980, 210(4466):207-210.
45. Compton M.A. Cold-pressor pain tolerance in opiate and cocaine abusers: correlates of drug type and use status. J. Pain Symptom Manage. 1994, 9:462-473.
46. Compton P., Estepa C.A. Addiction in patients with chronic pain. Lippincotts Prim. Care Pract. 2000, 4:254-272.
47. Compton P., Charuvastra V.C., Kintaudi K., Ling W. Pain responses in methadone-maintained opioid abusers. J. Pain Symptom Manage. 2000, 20:237-245.
48. Cooper S.J. Anaesthetisation of prefrontal cortex and response to noxious stimulation. Nature 1975, 254:439-440.
49. Crespo J.A., Oliva J.M., Ghasemzadeh M.B., Kalivas P.W., Ambrosio E. Neuroadaptive changes in NMDAR1 gene expression after extinction of cocaine self-administration. Ann. N. Y. Acad. Sci. 2002, 965:78-91.
50. Crowley T.J., Macdonald M.J., Whitmore E.A., Mikulich S.K. Cannabis dependence, withdrawal, and reinforcing effects among adolescents with conduct symptoms and substance use disorders. Drug Alcohol Depend. 1998, 50:27-37.
51. Dalley J.W., Cardinal R.N., Robbins T.W. Prefrontal executive and cognitive functions in rodents: neural and neurochemical substrates. Neurosci. Biobehav. Rev. 2004, 28:771-784.
52. Dalley J.W., Fryer T.D., Brichard L., Robinson E.S., Theobald D.E., Laane K., Pena Y., Murphy E.R., Shah Y., Probst K., et al. Nucleus accumbens D2/3 receptors predict trait impulsivity and cocaine reinforcement. Science 2007, 315:1267-1270.
53. Dalley J.W., Laane K., Pena Y., Theobald D.E., Everitt B.J., Robbins T.W. Attentional and motivational deficits in rats withdrawn from intravenous self-administration of cocaine or heroin. Psychopharmacology (Berlin) 2005, 182:579-587.
54. Dalley J.W., Laane K., Theobald D.E., Pena Y., Bruce C.C., Huszar A.C., Wojcieszek M., Everitt B.J., Robbins T.W. Enduring deficits in sustained visual attention during withdrawal of intravenous methylenedioxymethamphetamine self-administration in rats: results from a comparative study with d-amphetamine and methamphetamine. Neuropsychopharmacology 2007, 32:1195-1206.
55. Damasio H., Grabowski T., Frank R., Galaburda A.M., Damasio A.R. The return of Phineas Gage: clues about the brain from the skull of a famous patient. Science 1994, 264:1102-1105.
56. Davidson R.J., Putnam K.M., Larson C.L. Dysfunction in the neural circuitry of emotion regulation-a possible prelude to violence. Science 2000, 289:591-594.
57. Dawes M.A., Tarter R.E., Kirisci L. Behavioral selfregulation: correlates and 2 year follow-ups for boys at risk for substance abuse. Drug Alcohol Depend. 1997, 45:165-176.
58. de Wit H., Uhlenhuth E.H., Johanson C.E. Individual differences in the reinforcing and subjective effects of amphetamine and diazepam. Drug Alcohol Depend. 1986, 16:341-360.
59. Denoble U., Begleiter H. Response suppression on a mixed schedule of reinforcement during alcohol withdrawal. Pharmacol. Biochem. Behav. 1976, 5:227-229.
60. Deroche-Gamonet V., Belin D., Piazza P.V. Evidence for addiction-like behavior in the rat. Science 2004, 305:1014-1017.
61. Dias-Ferreira E., Sousa J.C., Melo I., Morgado P., Mesquita A.R., Cerqueira J.J., Costa R.M., Sousa N. Chronic stress causes frontostriatal reorganization and affects decision-making. Science 2009, 325:621-625.
62. Dias R., Robbins T.W., Roberts A.C. Dissociable forms of inhibitory control within prefrontal cortex with an analog of the Wisconsin Card Sort Test: restriction to novel situations and independence from " on-line" processing. J. Neurosci. 1997, 17:9285-9297.
63. Dietz D.M., Dietz K.C., Moore S., Ouimet C.C., Kabbaj M. Repeated social defeat stress-induced sensitization to the locomotor activating effects of d-amphetamine: role of individual differences. Psychopharmacology (Berlin) 2008, 198:51-62.
64. Diorio D., Viau V., Meaney M.J. The role of the medial prefrontal cortex (cingulate gyrus) in the regulation of hypothalamic-pituitary-adrenal responses to stress. J. Neurosci. 1993, 13:3839-3847.
65. Dobi A., Margolis E.B., Wang H.L., Harvey B.K., Morales M. Glutamatergic and nonglutamatergic neurons of the ventral tegmental area establish local synaptic contacts with dopaminergic and nondopaminergic neurons. J. Neurosci. 2010, 30:218-229.
66. Doverty M., Somogyi A.A., White J.M., Bochner F., Beare C.H., Menelaou A., Ling W. Methadone maintenance patients are cross-tolerant to the antinociceptive effects of morphine. Pain 2001, 93:155-163.
67. Doverty M., White J.M., Somogyi A.A., Bochner F., Ali R., Ling W. Hyperalgesic responses in methadone maintenance patients. Pain 2001, 90:91-96.
68. Drabant E.M., McRae K., Manuck S.B., Hariri A.R., Gross J.J. Individual differences in typical reappraisal use predict amygdala and prefrontal responses. Biol. Psychiatry 2009, 65:367-373.
69. Druhan J.P., Fibiger H.C., Phillips A.G. Amphetamine-like stimulus properties produced by electrical stimulation of reward sites in the ventral tegmental area. Behav. Brain Res. 1990, 38:175-184.
70. Epping-Jordan M.P., Watkins S.S., Koob G.F., Markou A. Dramatic decreases in brain reward function during nicotine withdrawal. Nature 1998, 393:76-79.
71. Erb S., Stewart J. A role for the bed nucleus of the stria terminalis, but not the amygdala, in the effects of corticotropin-releasing factor on stress-induced reinstatement of cocaine seeking. J. Neurosci. 1999, 19:RC35.
72. Erb S., Hitchcott P.K., Rajabi H., Mueller D., Shaham Y., Stewart J. Alpha-2 adrenergic receptor agonists block stress-induced reinstatement of cocaine seeking. Neuropsychopharmacology 2000, 23:138-150.
73. Erb S., Shaham Y., Stewart J. Stress reinstates cocaine-seeking behavior after prolonged extinction and a drug-free period. Psychopharmacology (Berlin) 1996, 128:408-412.
74. Erb S., Shaham Y., Stewart J. The role of corticotropin-releasing factor and corticosterone in stress- and cocaine-induced relapse to cocaine seeking in rats. J. Neurosci. 1998, 18:5529-5536.
75. Etkin A., Klemenhagen K.C., Dudman J.T., Rogan M.T., Hen R., Kandel E.R., Hirsch J. Individual differences in trait anxiety predict the response of the basolateral amygdala to unconsciously processed fearful faces. Neuron 2004, 44:1043-1055.
76. Everitt B.J., Robbins T.W. Neural systems of reinforcement for drug addiction: from actions to habits to compulsion. Nat. Neurosci. 2005, 8:1481-1489.
77. Fecteau S., Knoch D., Fregni F., Sultani N., Boggio P., Pascual-Leone A. Diminishing risk-taking behavior by modulating activity in the prefrontal cortex: a direct current stimulation study. J. Neurosci. 2007, 27:12500-12505.
78. Fecteau S., Pascual-Leone A., Zald D.H., Liguori P., Theoret H., Boggio P.S., Fregni F. Activation of prefrontal cortex by transcranial direct current stimulation reduces appetite for risk during ambiguous decision making. J. Neurosci. 2007, 27:6212-6218.
79. Ferrario C.R., Gorny G., Crombag H.S., Li Y., Kolb B., Robinson T.E. Neural and behavioral plasticity associated with the transition from controlled to escalated cocaine use. Biol. Psychiatry 2005, 58:751-759.
80. Fields H. State-dependent opioid control of pain. Nat. Rev. Neurosci. 2004, 5:565-575.
81. Fields H.L. Pain modulation: expectation, opioid analgesia and virtual pain. Prog. Brain Res. 2000, 122:245-253.
82. Figueiredo H.F., Bodie B.L., Tauchi M., Dolgas C.M., Herman J.P. Stress integration after acute and chronic predator stress: differential activation of central stress circuitry and sensitization of the hypothalamo-pituitary-adrenocortical axis. Endocrinology 2003, 144:5249-5258.
83. Figueiredo H.F., Bruestle A., Bodie B., Dolgas C.M., Herman J.P. The medial prefrontal cortex differentially regulates stress-induced c-fos expression in the forebrain depending on type of stressor. Eur. J. Neurosci. 2003, 18:2357-2364.
84. Fillingim R.B., King C.D., Ribeiro-Dasilva M.C., Rahim-Williams B., Riley J.L. Sex, gender, and pain: a review of recent clinical and experimental findings. J. Pain 2009, 10:447-485.
85. Flagel S.B., Watson S.J., Akil H., Robinson T.E. Individual differences in the attribution of incentive salience to a reward-related cue: influence on cocaine sensitization. Behav. Brain Res. 2008, 186(1):48-56.
86. Flagel S.B., Akil H., Robinson T.E. Individual differences in the attribution of incentive salience to reward-related cues: Implications for addiction. Neuropharmacology 2009, 56(S1):139-148.
87. Fodor J. The Modularity of Mind 1983, MIT Press, Cambridge.
88. Gabbott P.L., Warner T.A., Jays P.R., Salway P., Busby S.J. Prefrontal cortex in the rat: projections to subcortical autonomic, motor, and limbic centers. J. Comp. Neurol. 2005, 492(2):145-177.
89. Gauriau, C., Bernard, J.F., 2002. Pain pathways and parabrachial circuits in the rat. Exp. Physiol. 87(2) 251-258.
90. The New Cognitive Neurosciences 2000, MIT Press, Cambridge, Massachusetts. M.S. Gazzaniga (Ed.).
91. Gellert V.F., Sparber S.B. A comparison of the effects of naloxone upon body weight loss and suppression of fixed-ratio operant behavior in morphine-dependent rats. J. Pharmacol. Exp. Therap. 1977, 201:44-54.
92. George O., Ghozland S., Azar M.R., Cottone P., Zorrilla E.P., Parsons L.H., O'Dell L.E., Richardson H.N., Koob G.F. CRF-CRF1 system activation mediates withdrawal-induced increases in nicotine self-administration in nicotine-dependent rats. Proc. Natl. Acad. Sci. U.S.A. 2007, 104:17198-17203.
93. George O., Mandyam C.D., Wee S., Koob G.F. Extended access to cocaine self-administration produces long-lasting prefrontal cortex-dependent working memory impairments. Neuropsychopharmacology 2008, 33:2474-2482.
94. Gerfen C.R. The neostriatal mosaic: multiple levels of compartmental organization. Trends Neurosci. 1992, 15:133-139.
95. Giancola P.R., Moss H.B., Martin C.S., Kirisci L., Tarter R.E. Executive cognitive functioning predicts reactive aggression in boys at high risk for substance abuse: a prospective study. Alcohol. Clin. Exp. Res. 1996, 20:740-744.
96. Giancola P.R., Zeichner A., Yarnell J.E., Dickson K.E. Relation between executive cognitive functioning and the adverse consequences of alcohol use in social drinkers. Alcohol. Clin. Exp. Res. 1996, 20:1094-1098.
97. Gibson S.J., Helme R.D. Age-related differences in pain perception and report. Clin. Geriatr. Med. 2001, 17:433-456. v-vi.
98. Glimcher P.W., Rustichini A. Neuroeconomics: the consilience of brain and decision. Science 2004, 306:447-452.
99. Goldman-Rakic P.S. Circuitry of primate prefrontal cortex and the regulation of behavior by representational memory. Handbook of Physiology 1987, vol. 5:373-417. American Physiological Society, Bethesda, MD.
100. Goldman-Rakic P.S. Cellular basis of working memory. Neuron 1995, 14:477-485.
101. Goldstein R.Z., Volkow N.D. Drug addiction and its underlying neurobiological basis: neuroimaging evidence for the involvement of the frontal cortex. Am. J. Psychiatry 2002, 159:1642-1652.
102. Grant K.A., Shively C.A., Nader M.A., Ehrenkaufer R.L., Line S.W., Morton T.E., Gage H.D., Mach R.H. Effect of social status on striatal dopamine D2 receptor binding characteristics in cynomolgus monkeys assessed with positron emission tomography. Synapse 1998, 29(1):80-83.
103. Gray T.S., Piechowski R.A., Yracheta J.M., Rittenhouse P.A., Bethea C.L., Van de Kar L.D. Ibotenic acid lesions in the bed nucleus of the stria terminalis attenuate conditioned stress-induced increases in prolactin, ACTH and corticosterone. Neuroendocrinology 1993, 57:517-524.
104. Groenewegen H.J., Wright C.I., Uylings H.B. The anatomical relationships of the prefrontal cortex with limbic structures and the basal ganglia. J. Psychopharmacol. 1997, 11:99-106.
105. Hamann S., Canli T. Individual differences in emotion processing. Curr. Opin. Neurobiol. 2004, 14:233-238.
106. Han J.S., Neugebauer V. Synaptic plasticity in the amygdala in a visceral pain model in rats. Neurosci. Lett. 2004, 361:254-257.
107. Hare T.A., Camerer C.F., Rangel A. Self-control in decision-making involves modulation of the vmPFC valuation system. Science 2009, 324:646-648.
108. Heinz A., Löber S., Georgi A., Wrase J., Hermann D., Rey E.R., Wellek S., Mann K. Reward craving and withdrawal relief craving: assessment of different motivational pathways to alcohol intake. Alcohol. Alcohol. 2003, 38:35-39.
109. Herman J.P., Prewitt C.M., Cullinan W.E. Neuronal circuit regulation of the hypothalamo-pituitary-adrenocortical stress axis. Crit. Rev. Neurobiol. 1996, 10(3-4):371-394.
110. Herz A. Endogenous opioid systems and alcohol addiction. Psychopharmacology 1997, 129:99-111.
111. Holtzman, S.G., 1990. Discriminative stimulus effects of drugs: relationship to potential for abuse. In: Alder, M.W., Cowan, A. (Eds.), Testing and Evaluation of Drugs of Abuse. Modern Methods in Pharmacology, vol. 6. Wiley, New York, pp. 193-210.
112. Hooks M.S., Colvin A.C., Juncos J.L., Justice J.B. Individual differences in basal and cocaine-stimulated extracellular dopamine in the nucleus accumbens using quantitative microdialysis. Brain Res. 1992, 587:306-312.
113. Hurley K.M., Herbert H., Moga M.M., Saper C.B. Efferent projections of the infralimbic cortex of the rat. J. Comp. Neurol. 1991, 308:249-276.
114. Iadarola M.J., Berman K.F., Zeffiro T.A., Byas-Smith M.G., Gracely R.H., Max M.B., Bennett G.J. Neural activation during acute capsaicin-evoked pain and allodynia assessed with PET. Brain 1998, 121(Pt 5):931-947.
115. Imaki T., Nahan J.L., Rivier C., Sawchenko P.E., Vale W. Differential regulation of corticotropin-releasing factor mRNA in rat brain regions by glucocorticoids and stress. J. Neurosci. 1991, 11:585-599.
116. Jackson D.C., Malmstadt J.R., Larson C.L., Davidson R.J. Suppression and enhancement of emotional responses to unpleasant pictures. Psychophysiology 2000, 37(4):515-522.
117. Jentsch J.D., Taylor J.R. Impulsivity resulting from frontostriatal dysfunction in drug abuse: implications for the control of behavior by reward-related stimuli. Psychopharmacology (Berlin) 1999, 146:373-390.
118. Johnstone T., van Reekum C.M., Urry H.L., Kalin N.H., Davidson R.J. Failure to regulate: counterproductive recruitment of top-down prefrontal-subcortical circuitry in major depression. J. Neurosci. 2007, 27(33):8877-8884.
119. Kalivas P.W. Neurotransmitter regulation of dopamine neurons in the ventral tegmental area. Brain Res. Brain Res. Rev. 1993, 18(1):75-113.
120. Kassel J.D., Shiffman S., Gnys M., Paty J., Zettler-Segal M. Psychosocial and personality differences in chippers and regular smokers. Addict. Behav. 1994, 19:565-575.
121. Katz J.L., Goldberg S.R. Second-order schedules of drug injection: implications for understanding reinforcing effects of abused drugs. Adv. Subst. Abuse 1991, 4:205-223.
122. Khantzian E.J. The self-medication hypothesis of substance use disorders: a reconsideration and recent applications. Harvard Rev. Psychiatry 1997, 4:231-244.
123. Killcross S., Coutureau E. Coordination of actions and habits in the medial prefrontal cortex of rats. Cereb. Cortex 2003, 13:400-408.
124. Kilts C.D., Schweitzer J.B., Quinn C.K., Gross R.E., Faber T.L., Muhammad F., Ely T.D., Hoffman J.M., Drexler K.P. Neural activity related to drug craving in cocaine addiction. Arch. Gen. Psychiatry 2001, 58:334-341.
125. Knoch D., Gianotti L.R., Pascual-Leone A., Treyer V., Regard M., Hohmann M., Brugger P. Disruption of right prefrontal cortex by low-frequency repetitive transcranial magnetic stimulation induces risk-taking behavior. J. Neurosci. 2006, 26:6469-6472.
126. Koob G.F., Le Moal M. Neurobiology of Addiction 2006, Elsevier, China.
127. Koob G.F. Animal models of craving for ethanol. Addiction 2000, 95(Suppl 2):S73-S81.
128. Koob G.F., Le Moal M. Drug abuse: hedonic homeostatic dysregulation. Science 1997, 278:52-58.
129. Koob G.F., Le Moal M. Drug addiction, dysregulation of reward, and allostasis. Neuropsychopharmacology. 2001, 24(2):97-129.
130. Koob G.F., Le Moal M. Plasticity of reward neurocircuitry and the 'dark side' of drug addiction. Nat. Neurosci. 2005, 8:1442-1444.
131. Koob G.F., Le Moal M. Addiction and the brain antireward system. Annu. Rev. Psychol. 2008, 59:29-53.
132. Koob G.F., Volkow N.D. Neurocircuitry of addiction. Neuropsychopharmacology 2010, 35:217-238. [erratum: 35, 1051].
133. Koob G.F., Sanna P.P., Bloom F.E. Neuroscience of addiction. Neuron 1998, 21:467-476.
134. Kornetsky C., Esposito R.U. Euphorigenic drugs: effects on the reward pathways of the brain. Federat. Proc. 1979, 38:2473-2476.
135. Krawczyk D.C., Gazzaley A., D'Esposito M. Reward modulation of prefrontal and visual association cortex during an incentive working memory task. Brain Res. 2007, 1141:168-177.
136. Laulin J.P., Celerier E., Larcher A., Le Moal M., Simonnet G. Opiate tolerance to daily heroin administration: An apparent phenomenon associated with enhanced pain sensitivity. Neuroscience 1999, 89:631-636.
137. Le A.D., Harding S., Juzytsch W., Fletcher P.J., Shaham Y. The role of corticotropin-releasing factor in the median raphe nucleus in relapse to alcohol. J. Neurosci. 2002, 22:7844-7849.
138. Le A.D., Harding S., Juzytsch W., Watchus J., Shalev U., Shaham Y. The role of corticotrophin-releasing factor in stress-induced relapse to alcohol-seeking behavior in rats. Psychopharmacology (Berlin) 2000, 150:317-324.
139. LeDoux J.E. Emotion circuits in the brain. Annu. Rev. Neurosci. 2000, 23:155-184.
140. Lehofer M., Liebmann P.M., Moser M., Legl T., Pernhaupt G., Schauenstein K., Zapotoczky H.G. Decreased nociceptive sensitivity: a biological risk marker for opiate dependence?. Addiction 1997, 92(2):163-166.
141. Leyton M., Boileau I., Benkelfat C., Diksic M., Baker G., Dagher A. Amphetamine-induced increases in extracellular dopamine, drug wanting, and novelty seeking: a PET/[11C]raclopride study in healthy men. Neuropsychopharmacology 2002, 27:1027-1035.
142. Lim K.O., Choi S.J., Pomara N., Wolkin A., Rotrosen J.P. Reduced frontal white matter integrity in cocaine dependence: a controlled diffusion tensor imaging study. Biol. Psychiatry 2002, 51:890-895.
143. Linfoot I., Gray M., Bingham B., Williamson M., Pinel J.P., Viau V. Naturally occurring variations in defensive burying behavior are associated with differences in vasopressin, oxytocin, and androgen receptors in the male rat. Prog. Neuropsychopharmacol. Biol. Psychiatry 2009.
144. London E.D., Ernst M., Grant S., Bonson K., Weinstein A. Orbitofrontal cortex and human drug abuse: functional imaging. Cereb. Cortex 2000, 10:334-342.
145. Lorenz J., Minoshima S., Casey K.L. Keeping pain out of mind: the role of the dorsolateral prefrontal cortex in pain modulation. Brain 2003, 126:1079-1091.
146. Lucas L.R., Angulo J.A., Le Moal M., McEwen B.S., Piazza P.V. Neurochemical characterization of individual vulnerability to addictive drugs in rats. Eur. J. Neurosci. 1998, 10:3153-3163.
147. Makino S., Gold P.W., Schulkin J. Corticosterone effects on corticotropin-releasing hormone mRNA in the central nucleus of the amygdala and the parvocellular region of the paraventricular nucleus of the hypothalamus. Brain Res. 1994, 640:105-112.
148. Makris N., Gasic G.P., Seidman L.J., Goldstein J.M., Gastfriend D.R., Elman I., Albaugh M.D., Hodge S.M., Ziegler D.A., Sheahan F.S., et al. Decreased absolute amygdala volume in cocaine addicts. Neuron 2004, 44:729-740.
149. Mantsch J.R., Saphier D., Goeders N.E. Corticosterone facilitates the acquisition of cocaine self-administration in rats: opposite effects of the type II glucocorticoid receptor agonist dexamethasone. J. Pharmacol. Exp. Ther. 1998, 287:72-80.
150. Mantsch J.R., Yuferov V., Mathieu-Kia A.M., Ho A., Kreek M.J. Neuroendocrine alterations in a high-dose, extended-access rat self-administration model of escalating cocaine use. Psychoneuroendocrinology 2003, 28:836-862.
151. Marinelli M., White F.J. Enhanced vulnerability to cocaine self-administration is associated with elevated impulse activity of midbrain dopamine neurons. J. Neurosci. 2000, 20:8876-8885.
152. Martin-Fardon R., Ciccocioppo R., Massi M., Weiss F. Nociceptin prevents stress-induced ethanol- but not cocaine-seeking behavior in rats. Neuroreport 2000, 11:1939-1943.
153. Martin T.J., Kim S.A., Buechler N.L., Porreca F., Eisenach J.C. Opioid self-administration in the nerve-injured rat: relevance of antiallodynic effects to drug consumption and effects of intrathecal analgesics. Anesthesiology 2007, 106:312-322.
154. Mather M., Canli T., English T., Whitfield S., Wais P., Ochsner K., Gabrieli J.D., Carstensen L.L. Amygdala responses to emotionally valenced stimuli in older and younger adults. Psychol. Sci. 2004, 15:259-263.
155. Miller N.S., Gold M.S. Opiate prescription medication dependence and pain perceptions. J. Addict. Dis. 2007, 26(Suppl. 1):65-71.
156. Mishkin M. Perseveration of central sets after frontal lesions in man. The Frontal Granular Cortex and Behavior 1964, 219-294. McGraw-Hill, New York. J.M.W.K. Alkert (Ed.).
157. Morgan M.A., LeDoux J.E. Contribution of ventrolateral prefrontal cortex to the acquisition and extinction of conditioned fear in rats. Neurobiol. Learn. Mem. 1999, 72:244-251.
158. Morgan D., Grant K.A., Gage H.D., Mach R.H., Kaplan J.R., Prioleau O., Nader S.H., Buchheimer N., Ehrenkaufer R.L., Nader M.A. Social dominance in monkeys: dopamine D2 receptors and cocaine self-administration. Nat. Neurosci. 2002, 5(2):169-174.
159. Morley S., Davies C., Barton S. Possible selves in chronic pain: self-pain enmeshment, adjustment and acceptance. Pain 2005, 115:84-94.
160. Moussawi K., Pacchioni A., Moran M., Olive M.F., Gass J.T., Lavin A., Kalivas P.W. N-Acetylcysteine reverses cocaine-induced metaplasticity. Nat. Neurosci. 2009, 12:182-189.
161. Nader M.A., Morgan D., Gage H.D., Nader S.H., Calhoun T.L., Buchheimer N., Ehrenkaufer R., Mach R.H. ET imaging of dopamine D2 receptors during chronic cocaine self-administration in monkeys. Nat. Neurosci. 2006, 9(8):1050-1056.
162. Narayanan N.S., Horst N.K., Laubach M. Reversible inactivations of rat medial prefrontal cortex impair the ability to wait for a stimulus. Neuroscience 2006, 139:865-876.
163. Nestler E.J. Molecular basis of long-term plasticity underlying addiction. Nat. Rev. Neurosci. 2001, 2:119-128.
164. Nielsen C.S., Staud R., Price D.D. Individual differences in pain sensitivity: measurement, causation, and consequences. J. Pain 2009, 10:231-237.
165. O'Brien, C.P., Ehrman, R.N., Terns, J.N., 1986. Classical conditioning in human opioid dependence. In: Goldeberg, S.R. (Ed.), Behavioral Analysis of Drug Dependence S.I. Academic, New York, pp. 329-335.
166. Oades R.D., Halliday G.M. Ventral tegmental (A10) system: Neurobiology. 1. Anatomy and connectivity. Brain Res. 1987, 434:117-165.
167. Ochsner K.N., Bunge S.A., Gross J.J., Gabrieli J.D. Rethinking feelings: an FMRI study of the cognitive regulation of emotion. J. Cogn. Neurosci. 2002, 14(8):1215-1229.
168. Ochsner K.N., Ray R.D., Cooper J.C., Robertson E.R., Chopra S., Gabrieli J.D., Gross J.J. For better or for worse: neural systems supporting the cognitive down- and up-regulation of negative emotion. Neuroimage. 2004, 23(2):483-499.
169. Oswald L.M., Wong D.F., McCaul M., Zhou Y., Kuwabara H., Choi L., Brasic J., Wand G.S. Relationships among ventral striatal dopamine release, cortisol secretion, and subjective responses to amphetamine. Neuropsychopharmacology 2005, 30:821-832.
170. Passamonti L., Rowe J.B., Ewbank M., Hampshire A., Keane J., Calder A.J. Connectivity from the ventral anterior cingulate to the amygdala is modulated by appetitive motivation in response to facial signals of aggression. Neuroimage 2008, 43:562-570.
171. Perez-Pareja J., Borras C., Sese A., Palmer A. Pain perception and fibromyalgia. Actas Esp. Psiquiatr. 2005, 33:303-310.
172. Peyron R., Laurent B., Garcia-Larrea L. Functional imaging of brain responses to pain. A review and meta-analysis (2000). Neurophysiol. Clin. 2000, 30:263-288.
173. Phan K.L., Fitzgerald D.A., Nathan P.J., Moore G.J., Uhde T.W., Tancer M.E. Neural substrates for voluntary suppression of negative affect: a functional magnetic resonance imaging study. Biol. Psychiatry 2005, 57(3):210-219.
174. Phan K.L., Taylor S.F., Welsh R.C., Decker L.R., Noll D.C., Nichols T.E., Britton J.C., Liberzon I. Activation of the medial prefrontal cortex and extended amygdala by individual ratings of emotional arousal: a fMRI study. Biol. Psychiatry 2003, 53:211-215.
175. Piazza P.V., Le Moal M.L. Pathophysiological basis of vulnerability to drug abuse: role of an interaction between stress, glucocorticoids, and dopaminergic neurons. Annu. Rev. Pharmacol. Toxicol. 1996, 36:359-378.
176. Piazza P.V., Le Moal M. The role of stress in drug self-administration. Trends Pharmacol. Sci. 1998, 19:67-74.
177. Piazza P.V., Deminiere J.M., Le Moal M., Simon H. Factors that predict individual vulnerability to amphetamine self-administration. Science 1989, 245:1511-1513.
178. Piazza P.V., Maccari S., Deminiere J.M., Le Moal M., Mormede P., Simon H. Corticosterone levels determine individual vulnerability to amphetamine self-administration. Proc. Natl. Acad. Sci. U.S.A. 1991, 88:2088-2092.
179. Piazza P.V., Rouge-Pont F., Deminiere J.M., Kharoubi M., Le Moal M., Simon H. Dopaminergic activity is reduced in the prefrontal cortex and increased in the nucleus accumbens of rats predisposed to develop amphetamine self-administration. Brain Res. 1991, 567:169-174.
180. Piazza P.V., Rouge-Pont F., Deroche V., Maccari S., Simon H., Le Moal M. Glucocorticoids have state-dependent stimulant effects on the mesencephalic dopaminergic transmission. Proc. Natl. Acad. Sci. U.S.A. 1996, 93:8716-8720.
181. Ploghaus A., Tracey I., Gati J.S., Clare S., Menon R.S., Matthews P.M., Rawlins J.N. Dissociating pain from its anticipation in the human brain. Science 1999, 284:1979-1981.
182. Ploner M., Freund H.J., Schnitzler A. Pain affect without pain sensation in a patient with a postcentral lesion. Pain 1999, 81:211-214.
183. Porro C.A. Functional imaging and pain: behavior, perception, and modulation. Neuroscientist 2003, 9:354-369.
184. Pribram K.H., Mishkin M. Analysis of the effects of frontal lesions in monkey. III. Object alternation. J. Comp. Physiol. Psychol. 1956, 41-45.
185. Price D.D. Psychological and neural mechanisms of the affective dimension of pain. Science 2000, 288:1769-1772.
186. Radley J.J., Arias C.M., Sawchenko P.E. Regional differentiation of the medial prefrontal cortex in regulating adaptive responses to acute emotional stress. J. Neurosci. 2006, 26:12967-12976.
187. Radley J.J., Gosselink K.L., Sawchenko P.E. A discrete GABAergic relay mediates medial prefrontal cortical inhibition of the neuroendocrine stress response. J. Neurosci. 2009, 29:7330-7340.
188. Ragozzino M.E., Kim J., Hassert D., Minniti N., Kiang C. The contribution of the rat prelimbic-infralimbic areas to different forms of task switching. Behav. Neurosci. 2003, 117:1054-1065.
189. Rao S.G., Williams G.V., Goldman-Rakic P.S. Destruction and creation of spatial tuning by disinhibition: GABA(A) blockade of prefrontal cortical neurons engaged by working memory. J. Neurosci. 2000, 20:485-494.
190. Redish A.D., Jensen S., Johnson A. A unified framework for addiction: vulnerabilities in the decision process. Behav. Brain Sci. 2008, 31(4):415-437. (discussion 437-487).
191. Ren Z.Y., Shi J., Epstein D.H., Wang J., Lu L. Abnormal pain response in pain-sensitive opiate addicts after prolonged abstinence predicts increased drug craving. Psychopharmacology (Berlin) 2009, 204(3):423-429.
192. Reynolds S.M., Zahm D.S. Specificity in the projections of prefrontal and insular cortex to ventral striatopallidum and the extended amygdala. J. Neurosci. 2005, 25:11757-11767.
193. Ridderinkhof K.R., Ullsperger M., Crone E.A., Nieuwenhuis S. The role of the medial frontal cortex in cognitive control. Science 2004, 306(5695):443-447.
194. Robbins T.W. From arousal to cognition: the integrative position of the prefrontal cortex. Prog. Brain Res. 2000, 126:469-483.
195. Roberts A.J., Heyser C.J., Cole M., Griffin P., Koob G.F. Excessive ethanol drinking following a history of dependence: animal model of allostasis. Neuropsychopharmacology 2000, 22:581-594.
196. Robinson T.E., Berridge K.C. The neural basis of drug craving: an incentive-sensitization theory of addiction. Brain Res. Brain Res. Rev. 1993, 18:247-291.
197. Roiser J.P., de Martino B., Tan G.C., Kumaran D., Seymour B., Wood N.W., Dolan R.J. A genetically mediated bias in decision making driven by failure of amygdala control. J. Neurosci. 2009, 29:5985-5991.
198. Rouge-Pont F., Deroche V., Le Moal M., Piazza P.V. Individual differences in stress-induced dopamine release in the nucleus accumbens are influenced by corticosterone. Eur. J. Neurosci. 1998, 10:3903-3907.
199. Royer S., Pare D. Bidirectional synaptic plasticity in intercalated amygdala neurons and the extinction of conditioned fear responses. Neuroscience 2002, 115:455-462.
200. Sakurai Y., Sugimoto S. Effects of lesions of prefrontal cortex and dorsomedial thalamus on delayed go/no-go alternation in rats. Behav. Brain Res. 1985, 17:213-219.
201. Salomons T.V., Johnstone T., Backonja M.M., Shackman A.J., Davidson R.J. Individual differences in the effects of perceived controllability on pain perception: critical role of the prefrontal cortex. J. Cogn. Neurosci. 2007, 19:993-1003.
202. Schoenbaum G., Roesch M.R., Stalnaker T.A. Orbitofrontal cortex, decision-making and drug addiction. Trends Neurosci. 2006, 29:116-124.
203. Schuster C.R., Woods J.H. The conditioned reinforcing effects of stimuli associated with morphine reinforcement. Int. J. Addict. 1968, 3:223-230.
204. Scott L.V., Dinan T.G. Vasopressin and the regulation of hypothalamic-pituitary-adrenal axis function: implications for the pathophysiology of depression. Life Sci. 1998, 62(22):1985-1998.
205. Seiwell A.P., Reveron M.E., Duvauchelle C.L. Increased accumbens Cdk5 expression in rats after short-access to self-administered cocaine, but not after long-access sessions. Neurosci. Lett. 2007, 417:100-105.
206. Sesack S.R., Deutch A.Y., Roth R.H., Bunney B.S. Topographical organization of the efferent projections of the medial prefrontal cortex in the rat: an anterograde tract-tracing study with Phaseolus vulgaris leucoagglutinin. J. Comp. Neurol. 1989, 290(December (2)):213-242.
207. Sesack S.R., Carr D.B. Selective prefrontal cortex inputs to dopamine cells: implications for schizophrenia. Physiol. Behav. 2002, 77:513-517.
208. Sesack S.R., Pickel V.M. Prefrontal cortical efferents in the rat synapse on unlabeled neuronal targets of catecholamine terminals in the nucleus accumbens septi and on dopamine neurons in the ventral tegmental area. J. Comp. Neurol. 1992, 320:145-160.
209. Shaham Y., Funk D., Erb S., Brown T.J., Walker C.D., Stewart J. Corticotropin-releasing factor, but not corticosterone, is involved in stress-induced relapse to heroin-seeking in rats. J. Neurosci. 1997, 17:2605-2614.
210. Shaham Y., Highfield D., Delfs J., Leung S., Stewart J. Clonidine blocks stress-induced reinstatement of heroin seeking in rats: an effect independent of locus coeruleus noradrenergic neurons. Eur. J. Neurosci. 2000, 12:292-302.
211. Shaham Y., Shalev U., Lu L., De Wit H., Stewart J. The reinstatement model of drug relapse: history, methodology and major findings. Psychopharmacology (Berlin) 2003, 168(1-2):3-20.
212. Shalev U., Erb S., Shaham Y. Role of CRF and other neuropeptides in stress-induced reinstatement of drug seeking. Brain Res. 2009.
213. Shiffman S. Tobacco " chippers" -individual differences in tobacco dependence. Psychopharmacology (Berlin) 1989, 97(4):539-547.
214. Shin L.M., Liberzon I. The neurocircuitry of fear, stress, and anxiety disorders. Neuropsychopharmacology 2010, 35:169-191.
215. Solberg Nes L., Roach A.R., Segerstrom S.C. Executive functions, self-regulation, and chronic pain: a review. Ann. Behav. Med. 2009, 37:173-183.
216. Solomon R.L., Corbit J.D. An opponent-process theory of motivation. I. Temporal dynamics of affect. Psychol. Rev. 1974, 81:119-145.
217. Stinus L., Le Moal M., Koob G.F. Nucleus accumbens and amygdala are possible substrates for the aversive stimulus effects of opiate withdrawal. Neuroscience 1990, 37:767-773.
218. Sullivan R.M., Gratton A. Lateralized effects of medial prefrontal cortex lesions on neuroendocrine and autonomic stress responses in rats. J. Neurosci. 1999, 19:2834-2840.
219. Swanson L.W., Simmons D.M. Differential steroid hormone and neural influences on peptide mRNA levels in CRH cells of the paraventricular nucleus: a hybridization histochemical study in the rat. J. Comp. Neurol. 1989, 285:413-435.
220. Takagishi M., Chiba T. Efferent projections of the infralimbic (area 25) region of the medial prefrontal cortex in the rat: an anterograde tracer PHA-L study. Brain Res. 1991, 566:26-39.
221. Tanaka S. Architecture and dynamics of the primate prefrontal cortical circuit for spatial working memory. Neural Netw. 1999, 12:1007-1020.
222. Taylor S.F., Phan K.L., Decker L.R., Liberzon I. Subjective rating of emotionally salient stimuli modulates neural activity. Neuroimage 2003, 18:650-659.
223. Taylor S.F., Welsh R.C., Wager T.D., Phan K.L., Fitzgerald K.D., Gehring W.J. A functional neuroimaging study of motivation and executive function. Neuroimage 2004, 21:1045-1054.
224. Tom S.M., Fox C.R., Trepel C., Poldrack R.A. The neural basis of loss aversion in decision-making under risk. Science 2007, 315:515-518.
225. Tomie A., Aguado A.S., Pohorecky L.A., Benjamin D. Individual differences in pavlovian autoshaping of lever pressing in rats predict stress-induced corticosterone release and mesolimbic levels of monoamines. Pharmacol. Biochem. Behav. 2000, 65:509-517.
226. Treisman A. The binding problem. Curr. Opin. Neurobiol. 1996, 6(2):171-178.
227. Turnbull A.V., Rivier C. Corticotropin-releasing factor (CRF) and endocrine responses to stress: CRF receptors, binding protein, and related peptides. Proc. Soc. Exp. Biol. Med. 1997, 215:1-10.
228. Urry H.L., van Reekum C.M., Johnstone T., Kalin N.H., Thurow M.E., Schaefer H.S., Jackson C.A., Frye C.J., Greischar L.L., Alexander A.L., Davidson R.J. Amygdala and ventromedial prefrontal cortex are inversely coupled during regulation of negative affect and predict the diurnal pattern of cortisol secretion among older adults. J. Neurosci. 2006, 26:4415-4425.
229. Vanderschuren L.J., Everitt B.J. Drug seeking becomes compulsive after prolonged cocaine self-administration. Science 2004, 305:1017-1019.
230. Venkatraman V., Payne J.W., Bettman J.R., Luce M.F., Huettel S.A. Separate neural mechanisms underlie choices and strategic preferences in risky decision making. Neuron 2009, 62:593-602.
231. Vogt B.A. Pain and emotion interactions in subregions of the cingulate gyrus. Nat. Rev. Neurosci. 2005, 6:533-544.
232. Volkow N.D., Fowler J.S., Wang G.J. Role of dopamine in drug reinforcement and addiction in humans: results from imaging studies. Behav. Pharmacol. 2002, 13:355-366.
233. Volkow N.D., Fowler J.S., Wang G.J., Dewey S.L., Schlyer D., MacGregor R., Logan J., Alexoff D., Shea C., Hitzemann R., et al. Reproducibility of repeated measures of carbon-11-raclopride binding in the human brain. J. Nucl. Med. 1993, 34:609-613.
234. Volkow N.D., Wang G.J., Fowler J.S., Hitzemann R., Angrist B., Gatley S.J., Logan J., Ding Y.S., Pappas N. Association of methylphenidate-induced craving with changes in right striato-orbitofrontal metabolism in cocaine abusers: implications in addiction. Am. J. Psychiatry 1999, 156:19-26.
235. Voorn P., Vanderschuren L.J., Groenewegen H.J., Robbins T.W., Pennartz C.M. Putting a spin on the dorsal-ventral divide of the striatum. Trends Neurosci. 2004, 27:468-474.
236. Wager T.D., Rilling J.K., Smith E.E., Sokolik A., Casey K.L., Davidson R.J., Kosslyn S.M., Rose R.M., Cohen J.D. Placebo-induced changes in fMRI in the anticipation and experience of pain. Science 2004, 303:1162-1167.
237. Wang G.J., Volkow N.D., Fowler J.S., Cervany P., Hitzemann R.J., Pappas N.R., Wong C.T., Felder C. Regional brain metabolic activation during craving elicited by recall of previous drug experiences. Life Sci. 1999, 64:775-784.
238. Weiss F., Markou A., Lorang M.T., Koob G.F. Basal extracellular dopamine levels in the nucleus accumbens are decreased during cocaine withdrawal after unlimited-access self-administration. Brain Res. 1992, 593:314-318.
239. Wexler B.E., Gottschalk C.H., Fulbright R.K., Prohovnik I., Lacadie C.M., Rounsaville B.J., Gore J.C. Functional magnetic resonance imaging of cocaine craving. Am. J. Psychiatry 2001, 158:86-95.
240. Wikler A. Dynamics of drug dependence. Implications of a conditioning theory for research and treatment. Arch. Gen. Psychiatry 1973, 28:611-616.
241. Wikler A., Pescor F.T. Classical conditioning of a morphine abstinence phenomenon, reinforcement of opioid-drinking behavior and "relapse" in morphine-addicted rats. Psychopharmacologia. 1967, 10(3):255-284.
242. Wilson F.A., O'Scalaidhe S.P., Goldman-Rakic P.S. Functional synergism between putative gamma-aminobutyrate-containing neurons and pyramidal neurons in prefrontal cortex. Proc. Natl. Acad. Sci. U.S.A. 1994, 91:4009-4013.
243. Wise R.A. Action of drugs of abuse on brain reward systems. Pharmacol. Biochem. Behav. 1980, 13(Suppl. 1):213-223.
244. Wise R.A. The role of reward pathways in the development of drug dependence. Pharmacol. Ther. 1987, 35:227-263.
245. Wise R.A. Brain reward circuitry: insights from unsensed incentives. Neuron 2002, 36:229-240.
246. Wunderlich G.R., Raymond R., DeSousa N.J., Nobrega J.N., Vaccarino F.J. Decreased CCK(B) receptor binding in rat amygdala in animals demonstrating greater anxiety-like behavior. Psychopharmacology (Berlin) 2002, 164:193-199.
247. Xue G., Lu Z., Levin I.P., Weller J.A., Li X., Bechara A. Functional dissociations of risk and reward processing in the medial prefrontal cortex. Cereb. Cortex 2009, 19:1019-1027.
248. Zhang S., Tang J.S., Yuan B., Jia H. Inhibitory effects of electrical stimulation of ventrolateral orbital cortex on the rat jaw-opening reflex. Brain Res. 1998, 813:359-366.
249. Zhou Y., Spangler R., Ho A., Kreek M.J. Increased CRH mRNA levels in the rat amygdala during short-term withdrawal from chronic 'binge' cocaine. Brain Res. Mol. Brain Res. 2003, 114:73-79.
250. Zhou Y., Spangler R., Schlussman S.D., Ho A., Kreek M.J. Alterations in hypothalamic-pituitary-adrenal axis activity and in levels of proopiomelanocortin and corticotropin-releasing hormone-receptor 1 mRNAs in the pituitary and hypothalamus of the rat during chronic 'binge' cocaine and withdrawal. Brain Res. 2003, 964:187-199.
251. Zubieta J.K., Bueller J.A., Jackson L.R., Scott D.J., Xu Y., Koeppe R.A., Nichols T.E., Stohler C.S. Placebo effects mediated by endogenous opioid activity on mu-opioid receptors. J. Neurosci. 2005, 25:7754-7762.